Shopping Cart
- Remove All
- Your shopping cart is currently empty
Saroglitazar (Lipaglyn) is an agonist of PPAR with EC50 values of 0.65 pM and 3 nM for PPARα and PPARγ.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $153 | In Stock | |
5 mg | $327 | In Stock | |
10 mg | $496 | In Stock | |
1 mL x 10 mM (in DMSO) | $349 | In Stock |
Description | Saroglitazar (Lipaglyn) is an agonist of PPAR with EC50 values of 0.65 pM and 3 nM for PPARα and PPARγ. |
Targets&IC50 | PPARα:0.65 pM (EC50, HepG2 cell), PPARγ:3 nM (EC50, HepG2 cell) |
In vivo | In db/db mice, Saroglitazar (0.01-3 mg/kg; orally) reduces serum triglycerides, free fatty acids, and glucose in a dose-dependent manner (ED50 = 0.05, 0.19, and 0.19 mg/kg). Saroglitazar (1 mg/kg) significantly reduces serum insulin and AUC-glucose(91%)[3]. |
Alias | Lipaglyn |
Molecular Weight | 439.57 |
Formula | C25H29NO4S |
Cas No. | 495399-09-2 |
Storage | keep away from direct sunlight,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 22.5 mg/mL (51.2 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.